Primary Site >> Biliary tract Cancer

Gene >> MUC16

  • 1988
  • 1991
  • 1996
  • 2006
  • 2012
  • 2014
  • 2015
  • 2017
  • 2018
Ref: [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers].
PMID: 2456040
 Ref: Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer.
PMID: 1666951
 Ref: Alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9-producing gallbladder cancer.
PMID: 8887046
 Ref: Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder.
PMID: 17542293
 Ref: Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type.
PMID: 22286058
Ref: Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer.
PMID: 22340475
Ref: Intraductal tubular neoplasms of the bile ducts.
PMID: 23073323
Ref: Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
PMID: 23220842
 Ref: Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.
PMID: 24081806
Ref: Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
PMID: 24744600
Ref: Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma.
PMID: 25031748
Ref: [A case of intrahepatic cholangiocarcinoma difficult to distinguish from metastatic liver cancer].
PMID: 25731429
 Ref: Exploring the diagnosis markers for gallbladder cancer based on clinical data.
PMID: 26177708
 Ref: Ceruloplasmin as a prognostic marker in patients with bile duct cancer.
PMID: 28423673
 Ref: Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report.
PMID: 30271179